Inspirna

Haptena Therapeutics

This biotechnology company develops immunotherapies for patients with oncogene-driven cancers by integrating precision oncology with immune engineering.

SpringWorks Therapeutics

This biopharmaceutical company develops and commercialises targeted oncology medicines and therapies for patients with rare diseases and cancer.

Nuvectis Pharma

This biopharmaceutical company develops precision medicines and targeted small molecule therapeutics for patients with advanced cancers and other serious conditions.

Nuvation Bio

This biopharmaceutical company develops and commercialises targeted oncology therapies for patients with cancers that have unmet medical needs.

Momentous Therapeutics

This company develops pan-cancer drugs and therapeutic treatments for the pharmaceutical industry to address challenging biological targets.

Accent Therapeutics

This biopharmaceutical company develops small molecule precision therapies for patients with various types of cancer.

IntrepidiaBio

This biopharmaceutical company develops therapeutic products to address unmet medical needs for patients.

Meliora Therapeutics

This company develops a machine-learning platform to identify drug mechanisms and create precision oncology treatments for pharmaceutical partners and cancer patients.